Gene765
CA6: carbonic anhydrase 6
13 sourcesgene-search-2026-11-13-0.2.1
Cite this record
ConductScience Library. CA6: carbonic anhydrase 6. Genes, record 765. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/765
Gene
Connected records6
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Drugs and targets2
Diseases4
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P23280 | Carbonic anhydrase 6 | 308 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents90
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260201011 A1 | 2026-07-16 | 1951 | P23280 | Espacenet |
| US 20260193644 A1 | 2026-07-09 | 10192 | P23280 | Espacenet |
| US 20260196299 A1 | 2026-07-09 | 310 | P23280 | Espacenet |
| US 20260196299 A1 | 2026-07-09 | 52 | P23280 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 5706 | P23280 | Espacenet |
| US 20260125700 A1 | 2026-05-07 | 1952 | P23280 | Espacenet |
| US 20260125701 A1 | 2026-05-07 | 1952 | P23280 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 40021 | P23280 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 9920 | P23280 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 10192 | P23280 | Espacenet |
Drugs2
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
Trials2
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT05885646 | SULTHIAME | ClinicalTrials.gov | ||
| NCT05236842 | SULTHIAME | PHASE2 | ClinicalTrials.gov |
NIH grants439
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CA6 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30EY014801 | Miami Center for Vision Research | 3 | 2025 |
| I01BX004893 | Lipid mediators and their signaling in ocular surface inflammation and meibomian gland dysfunction | 2 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 2 | 2025 |
| R35GM134867 | ATP-driven detection of foreign proteins triggers diverse mechanisms of cellular defense and phage-mediated counter defense | 2 | 2025 |
| ZIAHD002400 | The Role Of Subclinical Infection And Cytokines In Preterm Parturition | 2 | 2025 |
| K23HL171855 | Mixed meal tolerance test elicited metabolite responses as novel markers of cardiometabolic risk | 1 | 2025 |
| P01CA120964 | Molecular Pathogenesis of the Hamartoma Syndromes | 1 | 2025 |
| P01HL158502 | Atrial Fibrillation Post-GWAS: Mechanisms to Treatment | 1 | 2025 |
Source NIH's project files
Papers930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential Expression of Human and Bacterial Proteins Reveals Microbiome-Host Crosstalk in Metabolic Disorders. | Proteomics Clin Appl | 2026 | 42615576 | PubTator, text mining | PubMed |
| Carbonic anhydrase VI. | Enzymes | 2026 | 42486545 | PubTator, text mining | PubMed |
| Relevance of autoantibodies to carbonic anhydrase 6 (CA6), parotid secretory protein (PSP) and salivary gland protein 1 (SP1) to dry eye disease (DED). | BMJ Open Ophthalmol | 2026 | 42264541 | PubTator, text mining | PubMed |
| Dietary patterns characterized by high fiber intake in vegan and omnivorous individuals are associated with distinct salivary proteomic signatures linked to oral homeostasis. | Clin Oral Investig | 2026 | 42249210 | PubTator, text mining | PubMed |
| Mechanistic basis for selective Csm6-2 activation by cyclic penta-adenylate in a type III CRISPR-Cas system. | EMBO J | 2026 | 41917262 | PubTator, text mining | PubMed |
| Precision Diagnostics in Primary Sjögren's Syndrome: Advances in Biomarkers, Epigenetic Markers, Immune Pathways, and Clinical Translation. | Front Biosci (Landmark Ed) | 2026 | 41914277 | PubTator, text mining | PubMed |
| Structural and functional insights into the adenosine deaminase of the type III-B CRISPR-Cas system. | Nucleic Acids Res | 2026 | 41841492 | PubTator, text mining | PubMed |
| Utility of the Early Sjögren Antibody Panel as a Diagnostic Marker for Sensory Neuropathy. | Muscle Nerve | 2026 | 41839642 | PubTator, text mining | PubMed |
| Non-Conventional and Emerging Autoantibodies in Sjögren's Disease. | J Inflamm Res | 2026 | 41798638 | PubTator, text mining | PubMed |
| Companion Diagnostics in Clinical Therapy: Current Applications and Future Directions. | MedComm (2020) | 2026 | 41777248 | PubTator, text mining | PubMed |
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/765
GET https://conductscience.org/api/genes/v1/765/patents?page=2